Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-02-07

Clinical Trial Update: Pharmacokinetics and Pharmacodynamics Comparison Study Between Two Pegfilgrastim Formulations [Phase 1]

View source ↗

Summary

This Phase 1 study compares two pegfilgrastim formulations for pharmacokinetics and pharmacodynamics in neutropenia patients and healthy volunteers. The trial h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • pegfilgrastim formulation A (pegfilgrastim)
  • pegfilgrastim formulation B (pegfilgrastim)

Snippet

Sponsor: Eurofarma Laboratorios S.A. | Conditions: Neutropenia, Healthy | Phase 1 | Status: COMPLETED